Technical Analysis for NNVC - NanoViricides, Inc.

Grade Last Price % Change Price Change
grade F 0.275 0.04% 0.00
NNVC closed up 0.04 percent on Tuesday, March 19, 2019, on 70 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical NNVC trend table...

Date Alert Name Type % Chg
Mar 19 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Mar 19 Stochastic Buy Signal Bullish 0.00%
Mar 19 Narrow Range Bar Range Contraction 0.00%
Mar 19 Wide Bands Range Expansion 0.00%
Mar 19 Oversold Stochastic Weakness 0.00%
Mar 18 Narrow Range Bar Range Contraction 0.04%
Mar 18 Wide Bands Range Expansion 0.04%
Mar 18 Oversold Stochastic Weakness 0.04%
Mar 15 Wide Bands Range Expansion 3.77%
Mar 15 Oversold Stochastic Weakness 3.77%

Older signals for NNVC ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
NanoViricides, Inc. a nano-biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of viral infections. The company is developing anti-influenza drug candidates at advanced pre-clinical stage, which include two FluCide drugs comprising NV-INF-2, an oral anti-influenza drug and NV-INF-1, a injectable anti-influenza drug for novel strain of H7N9, Bird Flu H5N1, and other Highly Pathogenic Influenzas; HIVCide, an anti-human immunodeficiency virus (HIV) drug candidate that could enable a functional cure for HIV/AIDS; HerpeCide, a skin cream or gel formulation for the treatment of oral and genital herpes lesions; Nanoviricide anti-viral eye drops against external eye viral infections; and DengueCide, a treatment against Dengue viruses. It is also developing RabiCide, an anti-rabies nanoviricide; and Nanoviricide for the treatment of various strains of Ebola and Marburg filoviruses. The company has licenses to develop drugs for the treatment of human viral diseases, such as H5N1 (avian flu), human influenza, human immunodeficiency virus (HIV/AIDS), hepatitis B virus, hepatitis C virus, herpes simplex virus, and rabies; and dengue viruses, Japanese encephalitis virus, West Nile virus, viruses causing viral conjunctivitis and ocular herpes, and Ebola/Marburg viruses, as well as viral diseases of the eye comprising epidemic kerato-conjunctivitis and herpes keratitis. NanoViricides, Inc. was founded in 2005 and is based in West Haven, Connecticut.
Medicine Medical Specialties Infectious Diseases Infection Influenza HIV Hiv/Aids Antiviral Drug Virus Viral Diseases Herpes Simplex Herpes Simplex Virus Rabies Ebola Epidemiology Genital Herpes Human Influenza
Is NNVC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 0.909
52 Week Low 0.2
Average Volume 327,746
200-Day Moving Average 0.3573
50-Day Moving Average 0.335
20-Day Moving Average 0.3435
10-Day Moving Average 0.2843
Average True Range 0.0526
ADX 18.21
+DI 20.6817
-DI 18.1016
Chandelier Exit (Long, 3 ATRs ) 0.5222
Chandelier Exit (Short, 3 ATRs ) 0.4214
Upper Bollinger Band 0.4965
Lower Bollinger Band 0.1905
Percent B (%b) 0.28
BandWidth 89.082969
MACD Line -0.027
MACD Signal Line -0.0167
MACD Histogram -0.0103
Fundamentals Value
Market Cap 17.41 Million
Num Shares 63.3 Million
EPS -0.17
Price-to-Earnings (P/E) Ratio -1.62
Price-to-Sales 0.00
Price-to-Book 3.04
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.31
Resistance 3 (R3) 0.31 0.30 0.30
Resistance 2 (R2) 0.30 0.29 0.30 0.30
Resistance 1 (R1) 0.29 0.29 0.29 0.29 0.30
Pivot Point 0.28 0.28 0.28 0.28 0.28
Support 1 (S1) 0.27 0.27 0.27 0.27 0.25
Support 2 (S2) 0.26 0.27 0.26 0.25
Support 3 (S3) 0.25 0.26 0.25
Support 4 (S4) 0.25